Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cleary

Showing results (121-130 of 360) with videos related to

Pageof 36
Sort By:
RNA (New York, N.Y.)|March 30, 2010
Reduced seed region-based off-target activity with lentivirus-mediated RNAiRichard A Klinghoffer, Jill Magnus, Janell Schelter, et al.
The Journal of Surgical Research|June 11, 2019
Risk Factors for Venous Thromboembolism in Children and Young Adults With Inflammatory Bowel DiseaseKerri McKie, Robert J McLoughlin, Michael P Hirsh, et al.
Medicine and Science in Sports and Exercise|January 1, 1983
Physiological adjustments to higher- or lower-intensity exercise in eldersD T Badenhop, P A Cleary, S F Schaal, et al.
Eye (London, England)|September 25, 2007
Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-month resultsC A Cleary, S Jungkim, K Ravikumar, et al.
Acta Paediatrica (Oslo, Norway : 1992)|August 31, 2002
Cardiovascular changes in children with mucopolysaccharide disordersU R Mohan, A A Hay, M A Cleary, et al.
American Journal of Medical Genetics. Part A|August 7, 2013
A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutationsRojeen Shahni, Yehani Wedatilake, Maureen A Cleary, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 1, 1997
Visual symptoms after optic neuritis. Results from the Optic Neuritis Treatment TrialP A Cleary, R W Beck, L B Bourque, et al.
The Journal of Pediatrics|December 18, 2001
Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT)N H White, P A Cleary, W Dahms, et al.
Diabetes Care|May 1, 2007
The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications studyAndrew D Paterson, Brandy N Rutledge, Patricia A Cleary, et al.
Archives of Disease in Childhood|October 26, 2005
The significance of elevated CSF lactateS L Chow, Z J Rooney, M A Cleary, et al.
Pageof 36

Showing results (121-130 of 360) with videos related to

Sort By:
Pageof 36
RNA (New York, N.Y.)|March 30, 2010
Reduced seed region-based off-target activity with lentivirus-mediated RNAiRichard A Klinghoffer, Jill Magnus, Janell Schelter, et al.
The Journal of Surgical Research|June 11, 2019
Risk Factors for Venous Thromboembolism in Children and Young Adults With Inflammatory Bowel DiseaseKerri McKie, Robert J McLoughlin, Michael P Hirsh, et al.
Medicine and Science in Sports and Exercise|January 1, 1983
Physiological adjustments to higher- or lower-intensity exercise in eldersD T Badenhop, P A Cleary, S F Schaal, et al.
Eye (London, England)|September 25, 2007
Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-month resultsC A Cleary, S Jungkim, K Ravikumar, et al.
Acta Paediatrica (Oslo, Norway : 1992)|August 31, 2002
Cardiovascular changes in children with mucopolysaccharide disordersU R Mohan, A A Hay, M A Cleary, et al.
American Journal of Medical Genetics. Part A|August 7, 2013
A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutationsRojeen Shahni, Yehani Wedatilake, Maureen A Cleary, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 1, 1997
Visual symptoms after optic neuritis. Results from the Optic Neuritis Treatment TrialP A Cleary, R W Beck, L B Bourque, et al.
The Journal of Pediatrics|December 18, 2001
Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT)N H White, P A Cleary, W Dahms, et al.
Diabetes Care|May 1, 2007
The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications studyAndrew D Paterson, Brandy N Rutledge, Patricia A Cleary, et al.
Archives of Disease in Childhood|October 26, 2005
The significance of elevated CSF lactateS L Chow, Z J Rooney, M A Cleary, et al.
Pageof 36